Review Article| Volume 6, ISSUE 1, P99-104, May 2023

Download started.


Lower Face Botulinum Toxin


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Cosmetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Brys A, Cox SE. Clinical applications of neuromodulators: lower face/neck. In: Dayan S, Waldorf H, Bloom J, et al, editor. Rejuvination resource. Online, 2020. Available at: Accessed October, 2020.

        • Sundaram H.
        • Signorini M.
        • Liew S.
        • et al.
        Global aesthetics consensus group. global aesthetics consensus: botulinum toxin type a--evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications.
        Plast Reconstr Surg. 2016; 137: 518e-529e
        • Carruthers A.
        • Kane M.A.C.
        • Flynn T.C.
        • et al.
        MAcc8. The Convergence of medicine and neurotoxins: a focus on botulinum toxin type a and its application in aesthetic medicine—a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
        Dermatol Surg. 2013; 39: 493-509
        • Cohn J.E.
        • Greco T.M.
        Advanced techniques for the use of neurotoxins in non-surgical facial rejuvenation.
        Aesthetic Plast Surg. 2020; 44: 1788-1799
        • Benedetto A.
        Botulinum toxins in clinical aesthetic practice. Taylor & Francis Ltd, London2011
        • Choi D.Y.
        • Bae H.
        • Bae J.H.
        • et al.
        Effective locations for injecting botulinum toxin into the mentalis muscle; cadaveric and ultrasonographic study.
        Toxins. 2021; 13: 96
        • Yi K.H.
        • Lee J.H.
        • Lee K.
        • et al.
        Anatomical proposal for botulinum neurotoxin injection targeting the platysma muscle for treating platysmal band and jawline lifting: a review.
        Toxins. 2022; 14: 868
        • Trevidic P.
        • Sykes J.
        • Criollo-Lamilla G.
        Anatomy of the lower face and botulinum toxin injections.
        Plast Reconstr Surg. 2015; 136: 84S-91S
        • Almukhtar R.M.
        • Fabi S.G.
        The masseter muscle and its role in facial contouring, aging, and quality of life: a literature review.
        Plast Reconstr Surg. 2019; 143: 39e-48e
        • Hu K.S.
        • Kim S.T.
        • Hur M.S.
        • et al.
        Topography of the masseter muscle in relation to treatment with botulinum toxin type A.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110: 167-171
        • Sucupira E.
        • Abramovitz A.
        A simplified method for smile enhancement: botulinum toxin injection for gummy smile.
        Plast Reconstr Surg. 2012; 130: 726-728
        • Awaida C.J.
        • Jabbour S.F.
        • Rayess Y.A.
        • et al.
        Evaluation of the microbotox technique: an algorithmic approach for lower face and neck rejuvenation and a crossover clinical trial.
        Plast Reconstr Surg. 2018; 142: 640-649
        • Iranmanesh B.
        • Khalili M.
        • Mohammadi S.
        • et al.
        Employing microbotox technique for facial rejuvenation and face-lift.
        J Cosmet Dermatol. 2022; 21: 4160-4170
        • Wu W.T.L.
        Microbotox of the lower face and neck: evolution of a personal technique and its clinical effects.
        Plast Reconstr Surg. 2015; 136: 92S-100S
        • Yu N.
        • Liu Y.
        • Chen C.
        • et al.
        Paradoxical bulging of mentalis after botulinum toxin type A injection.
        J Cosmet Dermatol. 2020; 19: 1290-1293